Literature DB >> 24087956

[Vasomotor endothelial dysfunction in young men with grade 1 arterial hypertension].

A R Zairova1, E V Oshchepkova, A N Rogoza.   

Abstract

In order to study vasomotor endothelial function and risk factors of endothelial dysfunction in young men with grade 1 arterial hypertension (G1AH) we examined 76 men with G1AH and 30 healthy men aged 20-40 years. Flow-mediated vasodilatation (FMD) of the brachial artery was assessed by ultrasonic method of Celermajer D.S. Vasomotor endothelial dysfunction (FMD<6%) was found significantly more frequently in men with G1AH than in healthy men (51% vs 13%). In healthy young men with normal blood pressure smoking was the main risk factor of endothelial dysfunction. In young men with G1AH risk factors for endothelial dysfunction were: family history of early cardiovascular disease, smoking, and elevation of low-density cholesterol level. Probability of endothelial dysfunction in the absence of these factors was low - 11%, in the presence of one factor it was 30%, two factors - 60%, and three factors - 83%. Elevated (>14.8%) red blood cell distribution width (RDW) was associated with endothelial dysfunction. Probability of endothelial dysfunction in young men with G1AH and elevated RDW was 5 times greater than in those with normal RDW.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24087956

Source DB:  PubMed          Journal:  Kardiologiia        ISSN: 0022-9040            Impact factor:   0.395


  2 in total

1.  Prognostic Significance of Red Cell Distribution Width in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis Emphysema.

Authors:  Aslıhan Gürün Kaya; Berna Akıncı Özyürek; Tuğçe Şahin Özdemirel; Miraç Öz; Yurdanur Erdoğan
Journal:  Med Princ Pract       Date:  2020-08-25       Impact factor: 1.927

2.  Red cell distribution width and end-organ damage in patients with systo-diastolic hypertension.

Authors:  Hamdi Pusuroglu; Ozgur Akgul; Mehmet Erturk; Ozgur Surgit; Omer Tasbulak; Emre Akkaya; Serkan Yazan; Mehmet Gül; Selahattin Türen
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.